TREACE MEDICAL CONCEPTS, INC. cotiza a 4.10 USD y tiene una capitalización bursátil de $267M. En los últimos 12 meses ha facturado $205M con un margen de flujo de caja libre del -13.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a wal…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.20 | $-0.12 | $-0.08 |
| Estimado | $-0.25 | $-0.30 | $-0.31 | $-0.14 |
| Sorpresa | — | +33.3% | +61.3% | +42.9% |
| Métrica | TMCI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 79.8% | 57.0% | +22.8% |
| Operating Margin | -25.5% | -38.6% | +13.2% |
| Net Margin | -27.7% | -33.6% | +5.8% |
| FCF Margin | -13.9% | -13.9% | 0.0% |
| ROE | -67.6% | -40.4% | -27.2% |
| ROA | -31.0% | -32.0% | +1.0% |
| Current Ratio | 4.31 | 2.84 | +1.47 |
| Debt / Equity | 0.64 | 0.28 | +0.36 |